This inventor holds 2 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignees: Innovacell Ag, Innovacell Gmbh. Active years: 2023-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023-2026
Title: Eva Margreiter: Innovator in Muscle-Derived Cell Research
Introduction
Eva Margreiter is a prominent inventor based in Innsbruck, Austria. She has made significant contributions to the field of biomedical research, particularly in the area of muscle-derived cells. Her innovative work aims to address critical health issues related to neuromyopathies and myopathies.
Latest Patents
Eva Margreiter holds a patent for her invention titled "Methods for obtaining muscle derived cells." This patent focuses on methods for obtaining skeletal muscle derived cells (SMDC) and their application in preventing and treating conditions such as urinary and anal or fecal incontinence. This groundbreaking research has the potential to improve the quality of life for many individuals suffering from these conditions.
Career Highlights
Throughout her career, Eva has demonstrated a strong commitment to advancing medical science. Her work at Innovacell AG has positioned her as a key player in the development of innovative therapies. With a patent portfolio that includes 1 patent, she continues to push the boundaries of what is possible in her field.
Collaborations
Eva Margreiter collaborates with esteemed colleagues such as Marco Thurner and Wolfgang Schwaiger. These partnerships enhance her research efforts and contribute to the overall success of her projects.
Conclusion
Eva Margreiter is a trailblazer in the field of muscle-derived cell research, with a focus on developing methods to treat debilitating conditions. Her innovative spirit and dedication to her work continue to inspire advancements in medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile